<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00954343</url>
  </required_header>
  <id_info>
    <org_study_id>2456/09</org_study_id>
    <nct_id>NCT00954343</nct_id>
  </id_info>
  <brief_title>Shockwave Treatment of Diabetic Foot Ulcer: Step I</brief_title>
  <acronym>STUF</acronym>
  <official_title>Shockwave Treatment of Diabetic Foot Ulcer. A Prospective, Controlled, Randomized Trial. Step 1</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technische Universität München</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Technische Universität München</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Extracorporeal Shock Wave treatment is a well established treatment in orthopedics.
      Considerable success has been reported after treatment of various soft tissue pathologies
      (Tendinitis, heel spur etc). In recent years, encouraging results have been reported
      concerning the effect of the shock-wave on chronic wounds. It has been reported that healing
      time can be considerably shortened if shock-waves are applied to the wound in addition to
      conventional wound treatment. Yet, randomized, controlled, prospective trials are missing.

      In this study, the effect of shock-waves on diabetic foot ulcer shall be assessed.

      The study is composed of 5 groups of which 4 groups receive shock wave treatments (each with
      a different protocol). One group serves as an untreated control group. All groups get
      standardized wound treatment and wound dressing.

      That shock-wave application protocol that shows the best results (rate of completely healed
      ulcer, most decrease of ulcer size) shall be tested in a further, sufficiently dimensioned,
      two-armed, randomized controlled trial (RCT).
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <start_date>August 2009</start_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage decrease of ulcer size twelve weeks after treatment begin (i.e. first shock wave treatment) compared to the baseline (ulcer size at first treatment)</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of completely healed ulcer 6, 9 and 12 weeks after first treatment</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage decrease of ulcer size 6 and 9 weeks after first treatment</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tissue oxygen concentration after shock wave treatment</measure>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Chronic Diabetic Foot Ulcers</condition>
  <arm_group>
    <arm_group_label>Group I</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Group II</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Group III</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Group IV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Group V</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Extracorporeal Shock Wave</intervention_name>
    <arm_group_label>Group I</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Extracorporeal Shock Wave</intervention_name>
    <arm_group_label>Group II</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Extracorporeal Shock Wave</intervention_name>
    <arm_group_label>Group III</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Extracorporeal Shock Wave</intervention_name>
    <arm_group_label>Group IV</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 and older

          -  Diabetes Type I or II

          -  Chronic ulcer on the foot

          -  Ulcer present for at least 6 weeks

          -  Wagner Grade 1 or 2

        Exclusion Criteria:

          -  Chronic rest pain

          -  Critical ischemia

          -  Gangrene

          -  Ankle-Arm-Index &lt; 0,5

          -  Critical ischemia treated within 6 weeks before possible enrollment

          -  Ulcer of Grade 3 or worse according to the Wagner Classification

          -  Osteomyelitis

          -  Affection of toes

          -  Necessity of surgical intervention

          -  Malalignment of the foot sustaining the ulcer

          -  Treatment of Ulcer with Prostaglandins or vasodilatators within the last 2 weeks

          -  Current therapy with corticoids

          -  Infection with HIV; Hepatitis

          -  Suppression of immune system (due to illness or medication)

          -  Medication with Vitamin-K-Antagonists

          -  Known hemophilia

          -  Sever Hypalbuminemia &lt; 2 g/dl

          -  Severe anemia

          -  Ulcer other than of diabetic origin

          -  Pregnant or breast-feeding women

          -  Known coagulopathies

          -  Implants such as artificial heart valves, joint replacement, bone replacement,
             osteosynthesis material

          -  Patients participating on other studies

          -  Chemotherapy within the last 60 days

          -  Mentally disabled patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hans Gollwitzer, PD Dr., CCRP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinik für Orthopädie und Unfallchirurgie Klinikum rechts der Isar</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinik für Orthopädie und Unfallchirurgie, Klinikum rechts der Isar</name>
      <address>
        <city>Munic</city>
        <state>Bavaria</state>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 31, 2009</study_first_submitted>
  <study_first_submitted_qc>August 6, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 7, 2009</study_first_posted>
  <last_update_submitted>March 18, 2013</last_update_submitted>
  <last_update_submitted_qc>March 18, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 19, 2013</last_update_posted>
  <keyword>Foot Ulcers</keyword>
  <keyword>Extracorporeal Shockwave</keyword>
  <keyword>Chronic wound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Diabetic Foot</mesh_term>
    <mesh_term>Foot Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

